Unresectable hepatoblastoma: current perspectives
Angela D Trobaugh-Lotrario,1 Rebecka L Meyers,2 Allison F O’Neill,3 James H Feusner4 1Department of Pediatric Hematology and Oncology, Providence Sacred Heart Children’s Hospital, Spokane, WA, 2Primary Children’s Hospital, University of Utah, Salt Lake City, UT, 3Dana-F...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7ba52c9a98f04c86931db689c529d9db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7ba52c9a98f04c86931db689c529d9db |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7ba52c9a98f04c86931db689c529d9db2021-12-02T03:57:23ZUnresectable hepatoblastoma: current perspectives1179-1535https://doaj.org/article/7ba52c9a98f04c86931db689c529d9db2017-02-01T00:00:00Zhttps://www.dovepress.com/unresectable-hepatoblastoma-current-perspectives-peer-reviewed-article-HMERhttps://doaj.org/toc/1179-1535Angela D Trobaugh-Lotrario,1 Rebecka L Meyers,2 Allison F O’Neill,3 James H Feusner4 1Department of Pediatric Hematology and Oncology, Providence Sacred Heart Children’s Hospital, Spokane, WA, 2Primary Children’s Hospital, University of Utah, Salt Lake City, UT, 3Dana-Farber Cancer Institute and Harvard University, Boston, MA, 4Children’s Hospital & Research Center Oakland, Oakland, CA, USA Abstract: Although rare, hepatoblastoma is the most common pediatric liver tumor. Complete resection is a critical component for cure; however, most patients will have tumors that are not resected at diagnosis. For these patients, administration of neoadjuvant chemotherapy renders tumors resectable in most patients. For patients whose tumors remain unresectable after chemotherapy, liver transplantation is indicated (in the absence of active unresectable metastatic disease). In patients whose tumors remain unresectable after conventional chemotherapy, interventional techniques may serve as a promising option to reduce tumor size, decrease systemic toxicity, decrease need for liver transplantation, and increase feasibility of tumor resection. Keywords: hepatoblastoma, unresectable, pediatricTrobaugh-Lotrario ADMeyers RLO'Neill AFFeusner JHDove Medical PressarticlehepatoblastomaunresectablepediatricDiseases of the digestive system. GastroenterologyRC799-869ENHepatic Medicine: Evidence and Research, Vol Volume 9, Pp 1-6 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
hepatoblastoma unresectable pediatric Diseases of the digestive system. Gastroenterology RC799-869 |
spellingShingle |
hepatoblastoma unresectable pediatric Diseases of the digestive system. Gastroenterology RC799-869 Trobaugh-Lotrario AD Meyers RL O'Neill AF Feusner JH Unresectable hepatoblastoma: current perspectives |
description |
Angela D Trobaugh-Lotrario,1 Rebecka L Meyers,2 Allison F O’Neill,3 James H Feusner4 1Department of Pediatric Hematology and Oncology, Providence Sacred Heart Children’s Hospital, Spokane, WA, 2Primary Children’s Hospital, University of Utah, Salt Lake City, UT, 3Dana-Farber Cancer Institute and Harvard University, Boston, MA, 4Children’s Hospital & Research Center Oakland, Oakland, CA, USA Abstract: Although rare, hepatoblastoma is the most common pediatric liver tumor. Complete resection is a critical component for cure; however, most patients will have tumors that are not resected at diagnosis. For these patients, administration of neoadjuvant chemotherapy renders tumors resectable in most patients. For patients whose tumors remain unresectable after chemotherapy, liver transplantation is indicated (in the absence of active unresectable metastatic disease). In patients whose tumors remain unresectable after conventional chemotherapy, interventional techniques may serve as a promising option to reduce tumor size, decrease systemic toxicity, decrease need for liver transplantation, and increase feasibility of tumor resection. Keywords: hepatoblastoma, unresectable, pediatric |
format |
article |
author |
Trobaugh-Lotrario AD Meyers RL O'Neill AF Feusner JH |
author_facet |
Trobaugh-Lotrario AD Meyers RL O'Neill AF Feusner JH |
author_sort |
Trobaugh-Lotrario AD |
title |
Unresectable hepatoblastoma: current perspectives |
title_short |
Unresectable hepatoblastoma: current perspectives |
title_full |
Unresectable hepatoblastoma: current perspectives |
title_fullStr |
Unresectable hepatoblastoma: current perspectives |
title_full_unstemmed |
Unresectable hepatoblastoma: current perspectives |
title_sort |
unresectable hepatoblastoma: current perspectives |
publisher |
Dove Medical Press |
publishDate |
2017 |
url |
https://doaj.org/article/7ba52c9a98f04c86931db689c529d9db |
work_keys_str_mv |
AT trobaughlotrarioad unresectablehepatoblastomacurrentperspectives AT meyersrl unresectablehepatoblastomacurrentperspectives AT oneillaf unresectablehepatoblastomacurrentperspectives AT feusnerjh unresectablehepatoblastomacurrentperspectives |
_version_ |
1718401559600037888 |